Quantcast
Home > Quotes > RCKT

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Quote & Summary Data

RCKT 
$12.25
*  
0.50
3.92%
Get RCKT Alerts
*Delayed - data as of Jul. 23, 2019  -  Find a broker to begin trading RCKT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    RCKT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 12.84 / $ 12.20
Share Volume
573,688
50 Day Avg. Daily Volume
357,939
Previous Close
$ 12.75
52 Week High / Low
$ 25.96 / $ 10.75
Market Cap
616,045,603
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
573,688
50 Day Avg. Daily Volume:
357,939

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.89

Trading Range

The current last sale of $12.25 is 13.95% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 12.84 $ 25.96
 Low: $ 12.20 $ 10.75

Company Description (as filed with the SEC)

On January 4, 2018, Inotek Pharmaceuticals Corporation ("Inotek") and privately held Rocket Pharmaceuticals, Ltd. ("Rocket Ltd") completed a business combination in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), dated as of September 12, 2017, by and among Inotek, Rome Merger Sub, a wholly owned subsidiary of Inotek ("Merger Sub"), and Rocket Ltd, pursuant to which Merger Sub merged with and into Rocket Ltd, with Rocket Ltd surviving as a wholly owned subsidiary of Inotek. This transaction is referred to as the "Reverse Merger." Immediately following the Reverse Merger, Inotek changed its name to "Rocket Pharmaceuticals, Inc." In connection with the closing of the Reverse Merger, our common stock began trading on The Nasdaq Global Market under the ticker symbol "RCKT" on January 5, 2018. The Reverse Merger has been accounted for as a reverse merger under the acquisition method of accounting.  ... More ...  



Risk Grade

Where does RCKT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 12.84
Open Date:
Jul. 23, 2019
Close Price:
$ 12.25
Close Date:
Jul. 23, 2019


Consensus Recommendation

Analyst Info